Man Group plc - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Man Group plc ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$48,436
-70.3%
49,424
-57.8%
0.00%
-100.0%
Q2 2023$162,979
+43.1%
117,251
+63.7%
0.00%
Q1 2023$113,911
+1.0%
71,642
+295.8%
0.00%
Q4 2022$112,763
-62.4%
18,100
-61.7%
0.00%
-100.0%
Q2 2022$300,000
-42.7%
47,203
-58.2%
0.00%
-50.0%
Q1 2022$524,000
+175.8%
112,903
+616.6%
0.00%
+100.0%
Q3 2021$190,000
-34.7%
15,756
+14.4%
0.00%0.0%
Q2 2021$291,000
-63.0%
13,778
-50.8%
0.00%
-66.7%
Q1 2021$786,000
-19.5%
28,026
-25.4%
0.00%
-25.0%
Q4 2020$977,000
+49.2%
37,580
+113.4%
0.00%
+33.3%
Q3 2020$655,000
-26.3%
17,611
+1.6%
0.00%
-25.0%
Q2 2020$889,000
+344.5%
17,330
+173.4%
0.00%
+300.0%
Q1 2020$200,000
-98.8%
6,338
-97.8%
0.00%
-98.2%
Q4 2019$16,875,000
+122.8%
282,996
+37.0%
0.06%
+96.4%
Q3 2019$7,575,000
-37.1%
206,627
-20.1%
0.03%
-34.9%
Q2 2019$12,034,000
+28.0%
258,683
+10.5%
0.04%
+19.4%
Q1 2019$9,399,000
+24.7%
234,117
+42.9%
0.04%
+5.9%
Q4 2018$7,535,000
+18.3%
163,786
+14.1%
0.03%
+47.8%
Q3 2018$6,370,000
+600.0%
143,568
+518.5%
0.02%
+475.0%
Q2 2018$910,00023,2110.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders